Ventac Partners

Ventac Partners investment thesis

Rancho Santa Fe Bio RSF Bio is a clinical stage cardiovascular therapeutics platform company based in San Diego, California. The company is developing Ataciguat: a small molecule drug developed to… Read More

Ventac Partners team (17)

Partners and principals at Ventac Partners:

• Kostas Alevizopoulos — sweet spot $1.5M
• Carlton Anderson — sweet spot $1.5M
• Randy Berholtz — sweet spot $1.5M
• Robert Buchanan — sweet spot $1.5M
• Rolf Ehrnström — sweet spot $1.5M
• Steven Glazer — sweet spot $1.5M
• Lars Hedbys — sweet spot $1.5M
• Dennis Henriksen — sweet spot $1.5M
• Melya Hughes Crameri — sweet spot $1.5M
• Lars J. Petersen — sweet spot $1.5M
• Aarti Kapoor — sweet spot $1.5M
• Mikael Ørum — sweet spot $1.5M
• Lasse Richter Petersen — sweet spot $1.5M
• Ferran Prat — sweet spot $1.5M
• Poul Sørensen — sweet spot $1.5M
• Neil Thomas — sweet spot $1.5M
• Dede Willis — sweet spot $1.5M

Ventac Partners portfolio companies

Companies listed on Ventac Partners's public materials include: Services, Company Building, Financing, Mergers & Acquisitions, Initial Public Offering, In- & Out-licensing, People, Portfolio, Transactions, News and Events, Show all, Current, Exits, Ambulero, Cenexum Technologies, Coegin Pharma, Idogen, Valink Therapeutics, Orbit Genomics, Rancho Santa Fe Bio, Regenesance, RhoVac, RORA Biologics, Mergers and Aquisitions, In and Out-Licensing, News & Events, info@ventac-partners.com.

Is Ventac Partners a fit for your round?

Upload your pitch deck and see whether anyone at Ventac Partners appears in your top matches.